Multidrug-resistant tuberculosis and migration to Europe

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

The first report of detecting the blaSIM-2 gene and determining the complete sequence of the SIM-encoding plasmid F. Sun, D. Zhou, Q. Wang, J. Feng,

Laboratory diagnosis and biosafety issues of biological warfare agents

Twelve years of dengue surveillance in Belgian travellers and significant increases in the number of cases in 2010 and 2013 J. Verschueren, L. Cnops,

G. Catho, S. Couraud, S. Grard, A. Bouaziz, A. Sénéchal, F. Valour, T

E. Svensson, J. Millet, A. Lindqvist, M. Olsson, M. Ridell, N. Rastogi

Migration and infectious diseases

Gut bacterial microbiota and obesity

I.J. Schalk Clinical Microbiology and Infection

Salvage therapy for multidrug-resistant tuberculosis

Approach to diagnosis of infective endocarditis

D. Khalil, M. Hultin, M.U. Rashid, B. Lund

Control of multidrug-resistant Gram-negative bacteria in low- and middle-income countries—high impact interventions without much resources N. Singh,

Herpes zoster in non-hospitalized children

Migrant health—a cause for concern?

Screening of migrants for tuberculosis identifies patients with multidrug-resistant tuberculosis but is not sufficient P. Helbling Clinical Microbiology.

Refugee crisis and re-emergence of forgotten infections in Europe

Controversies in guidelines for the control of multidrug-resistant Gram-negative bacteria in EU countries J.A. Otter, N.T. Mutters, E. Tacconelli, A.

E. Cambau, M. Drancourt Clinical Microbiology and Infection

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia D. Kese, M. Maticic, M. Potocnik Clinical.

Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice? T. Coenye, D. Goeres, F. Van Bambeke, T. Bjarnsholt

Clinical Microbiology and Infection

Surveillance of Legionnaires’ disease in Austria

H. Adibhesami, M. Douraghi, M. Rahbar, A. Abdollahi

Results from a mathematical model for human monocytic ehrlichiosis

Vector control: a cornerstone in the malaria elimination campaign

The first report of detecting the blaSIM-2 gene and determining the complete sequence of the SIM-encoding plasmid F. Sun, D. Zhou, Q. Wang, J. Feng,

Characterization of Mycobacterium tuberculosis isolated from cancer patients with suspected tuberculosis infection in Egypt: identification, prevalence,

Training for the infectious diseases speciality in Norway

Differential findings regarding molecular epidemiology of tuberculosis between two consecutive periods in the context of steady increase of immigration

Laboratory diagnosis and biosafety issues of biological warfare agents

S. Borrell, S. Gagneux Clinical Microbiology and Infection

Salvage therapy for multidrug-resistant tuberculosis

L. Zhang, Q. Meng, S. Chen, M. Zhang, B. Chen, B. Wu, G. Yan, X

In vitro selection of antibiotic resistance in Pseudomonas aeruginosa

G. Pappas Clinical Microbiology and Infection

Metagenomics and probiotics

M. Aires-de-Sousa Clinical Microbiology and Infection

Previously unknown species of Aspergillus

Laboratory diagnosis of Clostridium difficile disease

The practice of travel medicine in Europe

T.M. File Clinical Microbiology and Infection

Sexually acquired Zika virus: a systematic review

Tuberculosis drug-resistance in Lisbon, Portugal: a 6-year overview

Systematic review of antibiotic consumption in acute care hospitals

Update on antifungal resistance in Aspergillus and Candida

Tuberculosis transmission patterns among Spanish-born and foreign-born populations in the city of Barcelona S. Borrell, G. Tudó, E. Rey, J. González-Martín

Increased in vitro fitness of multi- and extensively drug-resistant F15/LAM4/KZN strains of Mycobacterium tuberculosis C.C. Naidoo, M. Pillay Clinical.

V. Vlahović-Palčevski, U. Dumpis, P. Mitt, J. Gulbinovič, J. Struwe, G

G.M. Rossolini, E. Mantengoli Clinical Microbiology and Infection

C. Wongsrichanalai, C.H. Sibley Clinical Microbiology and Infection

Statin use and clinical outcomes among pneumonia patients

Clinical Microbiology and Infection

I. Bitar, A. Piazza Clinical Microbiology and Infection

Clinical Microbiology and Infection

Survival of rhinoviruses on human fingers

Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe Robert D. Fox Clinical Microbiology.

Abstracts Clinical Microbiology and Infection

Virology: a scientific discipline facing new challenges

R. Khatib, G. Simeunovic, M. Sharma, M. G. Fakih, L. B. Johnson, L

Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group† H. Goossens Clinical.

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

Acquisition of second-line drug resistance and extensive drug resistance during recent transmission of Mycobacterium tuberculosis in rural China Y. Hu,

Typing of Clostridium difficile

Impact of antibiotic restrictions: the patient's perspective

Abstracts Clinical Microbiology and Infection

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Presentation transcript:

Multidrug-resistant tuberculosis and migration to Europe S. Hargreaves, K. Lönnroth, L.B. Nellums, I.D. Olaru, R.R. Nathavitharana, M. Norredam, J.S. Friedland Clinical Microbiology and Infection Volume 23, Issue 3, Pages 141-146 (March 2017) DOI: 10.1016/j.cmi.2016.09.009 Copyright © 2016 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Fig. 1 Multi-drug-resistant tuberculosis (MDR-TB) and migration in Europe. The boxes in this figure illustrate the proportion of TB cases and MDR-TB cases that occur in migrants (blue stacks) in each country. Columns in the boxes represent the percentage of foreign-born overall, among the total TB and MDR-TB cases reported in that country. On the map, the different shadings of the countries represent the proportions of foreign-born individuals living in that country that are comprised by migrants. Data taken from references [12,15–21,23,24,61]. Clinical Microbiology and Infection 2017 23, 141-146DOI: (10.1016/j.cmi.2016.09.009) Copyright © 2016 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions